Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Harari

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Nature Communications|March 12, 2020
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomesChloe Chong, Markus Müller, HuiSong Pak, et al.
Cancer Immunology Research|October 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer ImmunotherapyMyriam Ben Khelil, Maxime Fredon, Nawfel Adib, et al.
Journal for Immunotherapy of Cancer|October 12, 2019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8<sup>+</sup> T cellsBeatris Mastelic-Gavillet, Blanca Navarro Rodrigo, Laure Décombaz, et al.
Plos One|February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsEsther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
NPJ Vaccines|May 5, 2021
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
NPJ Vaccines|March 16, 2021
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
Science Advances|February 27, 2021
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancerAmélie Cachot, Mariia Bilous, Yen-Cheng Liu, et al.
Nature Biotechnology|June 25, 2024
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Biotechnology|May 7, 2024
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Biotechnology|October 11, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapyFlorian Huber, Marion Arnaud, Brian J Stevenson, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Nature Communications|March 12, 2020
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomesChloe Chong, Markus Müller, HuiSong Pak, et al.
Cancer Immunology Research|October 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer ImmunotherapyMyriam Ben Khelil, Maxime Fredon, Nawfel Adib, et al.
Journal for Immunotherapy of Cancer|October 12, 2019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8<sup>+</sup> T cellsBeatris Mastelic-Gavillet, Blanca Navarro Rodrigo, Laure Décombaz, et al.
Plos One|February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsEsther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
NPJ Vaccines|May 5, 2021
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
NPJ Vaccines|March 16, 2021
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
Science Advances|February 27, 2021
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancerAmélie Cachot, Mariia Bilous, Yen-Cheng Liu, et al.
Nature Biotechnology|June 25, 2024
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Biotechnology|May 7, 2024
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Biotechnology|October 11, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapyFlorian Huber, Marion Arnaud, Brian J Stevenson, et al.
Pageof 13